Ingevity (NGVT) Financials

$41.36 -1.45 (-3.39%)

Closing price 05/30/2025 03:59 PM Eastern

Extended Trading

$41.37 +0.01 (+0.02%)

As of 05/30/2025 05:30 PM Eastern

Annual Income Statements for Ingevity

This table shows Ingevity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	-430	-5.40	212	118	181	184	169	127	35	80	129
Consolidated Net Income / (Loss)	-430	-5.40	212	118	181	184	182	145	44	84	133
Net Income / (Loss) Continuing Operations	-430	-5.40	212	118	181	184	182	145	44	84	133
Total Pre-Tax Income	-536	-10	270	163	235	228	222	175	87	137	202
Total Operating Income	-276	83	324	290	273	271	253	191	102	156	216
Total Gross Profit	455	472	570	513	466	482	417	329	274	275	319
Total Revenue	1,406	1,692	1,668	1,392	1,216	1,293	1,134	972	908	958	1,036
Operating Revenue	1,406	1,692	1,668	1,392	1,216	1,293	1,134	972	908	958	1,036
Total Cost of Revenue	952	1,220	1,098	879	751	811	717	643	634	683	717
Operating Cost of Revenue	952	1,220	1,098	879	751	811	717	643	634	683	717
Total Operating Expenses	730	389	246	222	192	212	164	138	173	120	103
Selling, General & Admin Expense	167	184	199	179	149	163	132	106	114	110	108
Research & Development Expense	28	32	30	26	23	20	22	20	18	17	-
Impairment Charge	349	0.00	0.00	-	-	-	-	-	-	-	-
Restructuring Charge	187	174	5.00	17	20	27	10	11	41	-7.50	-5.60
Total Other Income / (Expense), net	-260	-93	-54	-128	-38	-43	-31	-16	-15	-19	-14
Interest Expense	98	93	62	52	47	55	33	18	19	20	16
Interest & Investment Income	7.70	6.30	7.50	4.00	4.90	7.70	3.40	2.30	1.40	0.00	-
Other Income / (Expense), net	-170	-5.70	-	-80	4.10	4.30	-1.00	-0.50	3.20	1.00	2.50
Income Tax Expense	-105	-4.70	58	45	54	44	40	30	43	52	70
Basic Earnings per Share	($11.85)	($0.15)	$5.54	$2.97	$4.39	$4.39	$4.02	$3.00	$0.83	$1.89	$3.06
Weighted Average Basic Shares Outstanding	36.35M	36.24M	37.15M	39.00M	40.47M	41.83M	42.04M	42.13M	42.11M	42.10M	-
Diluted Earnings per Share	($11.85)	($0.15)	$5.50	$2.95	$4.37	$4.35	$3.97	$2.97	$0.83	$1.89	$3.06
Weighted Average Diluted Shares Outstanding	36.35M	36.24M	37.15M	39.00M	40.47M	41.83M	42.04M	42.13M	42.11M	42.10M	-
Weighted Average Basic & Diluted Shares Outstanding	36.35M	36.24M	37.15M	39.00M	40.47M	41.83M	42.04M	42.13M	42.11M	42.10M	-

This table shows Ingevity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	21	17	-107	-284	-56	-117	25	36	51	16	75
Consolidated Net Income / (Loss)	21	17	-107	-284	-56	-117	25	36	51	16	75
Net Income / (Loss) Continuing Operations	21	17	-107	-284	-56	-117	25	36	51	16	75
Total Pre-Tax Income	27	8.80	-138	-335	-72	-154	32	48	64	20	96
Total Operating Income	50	55	-2.30	-311	-17	-109	57	69	66	38	109
Total Gross Profit	113	102	130	123	100	60	129	153	130	105	176
Total Revenue	284	299	377	391	340	372	446	482	393	384	482
Operating Revenue	284	299	377	391	340	372	446	482	393	384	482
Total Cost of Revenue	171	197	247	267	240	312	317	329	262	278	306
Operating Cost of Revenue	171	197	247	267	240	312	317	329	262	278	306
Total Operating Expenses	63	47	132	435	117	168	73	84	65	68	67
Selling, General & Admin Expense	43	39	39	41	47	43	40	52	49	56	54
Research & Development Expense	7.70	7.30	6.70	7.30	6.80	7.20	7.80	8.00	8.80	7.20	7.60
Other Operating Expenses / (Income)	12	-	-	24	63	-	-	3.00	5.60	1.50	3.30
Restructuring Charge	0.00	87	87	13	0.30	126	25	21	1.90	3.10	1.90
Total Other Income / (Expense), net	-24	-47	-136	-23	-55	-45	-24	-22	-1.40	-18	-14
Interest & Investment Income	-19	77	-24	-23	-22	71	-23	-22	-20	45	-12
Other Income / (Expense), net	-4.10	-	-112	-	-32	-	-1.30	-	18	-	-2.00
Income Tax Expense	6.30	-7.80	-31	-51	-16	-37	6.90	12	13	4.10	20
Basic Earnings per Share	$0.56	$0.45	($2.95)	($7.81)	($1.54)	($3.19)	$0.70	$0.98	$1.36	$0.44	$1.99
Weighted Average Basic Shares Outstanding	36.46M	36.35M	36.35M	36.35M	36.33M	36.24M	36.23M	36.22M	36.33M	37.15M	37.37M
Diluted Earnings per Share	$0.56	$0.45	($2.95)	($7.81)	($1.54)	($3.16)	$0.69	$0.97	$1.35	$0.43	$1.98
Weighted Average Diluted Shares Outstanding	36.46M	36.35M	36.35M	36.35M	36.33M	36.24M	36.23M	36.22M	36.33M	37.15M	37.37M
Weighted Average Basic & Diluted Shares Outstanding	36.46M	36.35M	36.35M	36.35M	36.33M	36.24M	36.23M	36.22M	36.33M	37.15M	37.37M

This table details how cash moves in and out of Ingevity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	-25	28	-196	20	194	-13	-10	41	-1.90	9.90	8.40
Net Cash From Operating Activities	129	205	313	293	352	276	252	174	128	72	139
Net Cash From Continuing Operating Activities	129	205	313	293	352	276	252	157	128	72	139
Net Income / (Loss) Continuing Operations	-430	-5.40	212	118	181	184	182	145	44	84	133
Consolidated Net Income / (Loss)	-430	-5.40	212	118	181	184	182	145	44	84	133
Depreciation Expense	108	123	109	110	100	85	57	40	39	35	32
Non-Cash Adjustments To Reconcile Net Income	585	307	78	149	31	50	34	1.90	53	-2.80	-4.80
Changes in Operating Assets and Liabilities, net	-135	-219	-85	-84	47	-43	-14	-19	-2.30	-44	-22
Net Cash From Investing Activities	-80	-77	-552	-139	-111	-658	-414	-59	-126	-89	-97
Net Cash From Continuing Investing Activities	-80	-77	-552	-139	-111	-658	-414	-59	-126	-89	-97
Purchase of Property, Plant & Equipment	-78	-110	-143	-104	-82	-115	-94	-53	-57	-101	-102
Acquisitions	0.00	0.00	-345	-35	0.00	-538	-316	0.00	-	-	-
Purchase of Investments	-0.30	-2.40	-77	-	-	-	-2.00	-4.00	-70	0.00	-
Sale and/or Maturity of Investments	0.00	32	15	0.00	0.00	-	1.10	1.00	0.00	0.00	0.00
Other Investing Activities, net	-1.60	3.40	-2.20	0.50	-29	-5.60	-4.10	-3.00	0.00	0.60	-1.00
Net Cash From Financing Activities	-70	-100	48	-133	-50	369	154	-58	-3.40	27	-32
Net Cash From Continuing Financing Activities	-70	-100	48	-133	-50	369	154	-58	-3.40	27	-32
Repayment of Debt	-471	-383	-972	-25	-882	-789	-7.10	-270	-13	-5.80	0.00
Repurchase of Common Equity	0.00	-92	-145	-109	-88	-6.40	-47	-6.60	0.00	0.00	-
Issuance of Debt	405	376	1,165	0.00	896	1,175	304	231	412	7.10	2.80
Other Financing Activities, net	-4.10	-0.80	1.00	1.60	24	-10	-0.40	-0.70	52	29	-31
Effect of Exchange Rate Changes	-4.20	-0.30	-6.00	-1.70	2.20	0.20	-1.40	-	-	-	-1.60
Cash Interest Paid	85	83	55	48	40	48	26	16	15	6.50	6.50
Cash Income Taxes Paid	27	30	55	54	47	15	35	62	22	1.40	0.00

This table details how cash moves in and out of Ingevity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	4.30	-67	28	20	-6.80	18	17	-9.20	1.80	6.90	-59
Net Cash From Operating Activities	25	65	47	30	-12	46	105	48	5.30	99	100
Net Cash From Continuing Operating Activities	25	65	47	30	-12	46	105	48	5.30	99	100
Net Income / (Loss) Continuing Operations	21	17	-107	-284	-56	-117	25	36	51	16	75
Consolidated Net Income / (Loss)	21	17	-107	-284	-56	-117	25	36	51	16	75
Depreciation Expense	25	25	26	27	30	31	31	30	31	30	26
Non-Cash Adjustments To Reconcile Net Income	27	-16	152	367	83	158	76	51	22	28	14
Changes in Operating Assets and Liabilities, net	-47	39	-25	-81	-68	-26	-26	-68	-98	25	-15
Net Cash From Investing Activities	-12	-28	-17	-18	-16	-25	-32	-23	2.50	-407	-86
Net Cash From Continuing Investing Activities	-12	-28	-17	-18	-16	-25	-32	-23	2.50	-407	-86
Purchase of Property, Plant & Equipment	-10	-25	-18	-18	-17	-29	-34	-22	-25	-49	-36
Sale of Property, Plant & Equipment	3.60	-	-	-	-	-	-	-	-	-	-
Other Investing Activities, net	-5.10	-2.80	0.60	0.30	0.30	4.50	3.50	-1.10	-3.50	1.10	-1.90
Net Cash From Financing Activities	-11	-98	-6.30	10	23	-6.50	-53	-35	-5.60	313	-72
Net Cash From Continuing Financing Activities	-11	-98	-6.30	10	23	-6.50	-53	-35	-5.60	313	-72
Repayment of Debt	-100	-351	-44	-20	-55	-143	-95	-85	-60	-59	-23
Issuance of Debt	92	254	38	31	81	137	42	108	90	377	-
Other Financing Activities, net	-3.00	-0.30	-0.40	-0.40	-3.00	-0.10	0.30	1.20	-2.20	0.80	0.70
Effect of Exchange Rate Changes	1.40	-5.80	5.40	-2.00	-1.80	2.70	-2.30	-0.30	-0.40	2.60	-1.40
Cash Interest Paid	15	24	19	25	17	25	18	25	15	19	7.20
Cash Income Taxes Paid	4.40	2.90	1.80	19	2.90	1.80	4.30	19	4.70	12	16

This table presents Ingevity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	2,023	2,623	2,737	2,469	2,335	2,142	1,315	930	833	779
Total Current Assets	493	659	683	725	629	463	423	369	295	296
Cash & Equivalents	68	96	77	275	258	57	78	88	31	32
Accounts Receivable	141	-	225	-	-	150	119	100	90	95
Inventories, net	227	309	335	241	189	213	191	160	151	149
Prepaid Expenses	57	72	47	47	34	44	35	21	24	20
Plant, Property, & Equipment, net	659	762	799	0.00	0.00	0.00	524	439	423	438
Total Noncurrent Assets	871	1,203	1,255	1,744	1,706	1,679	369	122	115	45
Goodwill	175	528	519	442	445	436	131	12	12	12
Intangible Assets	279	336	405	338	373	396	126	4.90	7.30	10
Noncurrent Deferred & Refundable Income Taxes	118	12	5.70	6.80	8.10	5.00	2.90	3.40	3.40	0.00
Other Noncurrent Operating Assets	299	327	326	958	879	841	110	102	92	23
Total Liabilities & Shareholders' Equity	2,023	2,623	2,737	2,469	2,335	2,142	1,315	930	833	779
Total Liabilities	1,827	1,992	2,038	1,795	1,692	1,611	977	652	698	261
Total Current Liabilities	264	363	304	269	223	216	183	153	137	100
Short-Term Debt	61	84	0.90	20	26	23	11	9.40	7.50	9.40
Accounts Payable	95	158	175	126	104	99	93	83	79	65
Accrued Expenses	58	72	54	52	47	33	37	20	19	15
Current Deferred & Payable Income Tax Liabilities	5.60	9.20	3.60	6.20	5.30	15	0.50	1.50	5.30	0.80
Current Employee Benefit Liabilities	28	20	53	48	25	28	42	39	26	10
Other Current Liabilities	17	19	17	17	16	17	0.00	-	-	-
Total Noncurrent Liabilities	1,563	1,629	1,735	1,526	1,469	1,395	793	499	561	162
Long-Term Debt	1,340	1,383	1,473	1,250	1,267	1,228	741	444	481	80
Noncurrent Deferred & Payable Income Tax Liabilities	56	71	107	115	117	100	37	41	70	74
Other Noncurrent Operating Liabilities	167	175	156	162	85	67	15	13	10	7.20
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	195	631	698	674	642	531	339	278	135	517
Total Preferred & Common Equity	195	631	698	674	642	531	339	264	127	514
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	195	631	698	674	642	531	339	264	127	514
Common Stock	177	165	153	137	122	113	99	141	130	0.00
Retained Earnings	572	1,002	1,008	796	678	497	314	143	16	0.00
Treasury Stock	-513	-510	-416	-272	-162	-75	-56	-7.70	-0.30	0.00
Accumulated Other Comprehensive Income / (Loss)	-41	-27	-47	13	4.70	-5.00	-18	-12	-19	-17

This table presents Ingevity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,056	2,212	2,276	2,567	2,767	2,828	2,772	2,335
Total Current Assets	530	637	686	669	735	764	716	645
Cash & Equivalents	72	136	107	89	85	68	78	72
Accounts Receivable	164	190	213	191	217	260	240	-
Inventories, net	245	261	302	326	387	387	361	282
Prepaid Expenses	49	50	63	64	47	50	37	43
Plant, Property, & Equipment, net	656	671	722	727	800	801	805	721
Total Noncurrent Assets	870	904	868	1,171	1,232	1,263	1,251	970
Goodwill	181	187	177	526	520	527	522	388
Intangible Assets	277	299	296	303	376	394	399	272
Noncurrent Deferred & Refundable Income Taxes	120	114	81	24	6.10	7.00	7.40	6.90
Other Noncurrent Operating Assets	293	304	315	319	331	335	323	303
Total Liabilities & Shareholders' Equity	2,056	2,212	2,276	2,567	2,767	2,828	2,772	2,335
Total Liabilities	1,822	1,997	1,991	1,999	2,048	2,114	2,047	1,702
Total Current Liabilities	265	361	358	352	305	311	279	290
Short-Term Debt	60	101	103	85	3.00	0.90	0.90	0.90
Accounts Payable	108	97	142	153	197	204	174	165
Accrued Expenses	57	117	70	71	65	64	55	57
Current Deferred & Payable Income Tax Liabilities	4.20	4.70	2.70	8.00	5.40	5.10	11	6.80
Current Employee Benefit Liabilities	19	24	21	17	17	20	22	45
Other Current Liabilities	16	18	19	19	18	18	16	16
Total Noncurrent Liabilities	1,557	1,636	1,634	1,647	1,743	1,803	1,768	1,411
Long-Term Debt	1,333	1,398	1,401	1,409	1,470	1,526	1,503	1,153
Noncurrent Deferred & Payable Income Tax Liabilities	59	66	62	64	105	110	108	107
Other Noncurrent Operating Liabilities	165	173	171	174	168	168	158	151
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	235	215	285	568	719	714	726	634
Total Preferred & Common Equity	235	215	285	568	719	714	726	634
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	235	215	285	568	719	714	726	634
Common Stock	181	175	172	170	163	164	159	148
Retained Earnings	593	555	663	946	1,119	1,094	1,058	992
Treasury Stock	-515	-513	-512	-512	-510	-510	-453	-411
Accumulated Other Comprehensive Income / (Loss)	-24	-3.50	-38	-36	-54	-34	-39	-95

This table displays calculated financial ratios and metrics derived from Ingevity's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.88%	1.43%	19.89%	14.42%	-5.94%	14.05%	16.58%	7.06%	-5.22%	-7.46%	0.00%
EBITDA Growth	-268.85%	-53.85%	35.05%	-13.52%	2.97%	19.30%	27.20%	72.06%	-27.93%	-23.76%	0.00%
EBIT Growth	-679.32%	-76.26%	53.87%	-24.09%	0.91%	9.22%	32.00%	81.70%	-33.01%	-28.33%	0.00%
NOPAT Growth	-433.78%	-77.26%	20.67%	-0.06%	-3.32%	5.31%	30.43%	205.84%	-45.99%	-32.19%	0.00%
Net Income Growth	-7,868.52%	-102.55%	79.17%	-34.90%	-1.25%	1.05%	25.21%	227.03%	-47.33%	-36.43%	0.00%
EPS Growth	-7,800.00%	-102.73%	86.44%	-32.49%	0.46%	9.57%	33.67%	257.83%	-56.08%	-38.24%	0.00%
Operating Cash Flow Growth	-37.30%	-34.56%	6.85%	-16.77%	27.82%	9.40%	44.58%	36.28%	77.15%	-47.87%	0.00%
Free Cash Flow Firm Growth	87.52%	186.88%	-178.37%	-14.61%	152.31%	-202.51%	-250.73%	220.22%	107.06%	0.00%	0.00%
Invested Capital Growth	-23.69%	-4.41%	25.60%	-0.58%	-2.75%	70.21%	57.54%	8.52%	3.15%	0.00%	0.00%
Revenue Q/Q Growth	-4.93%	-0.70%	2.94%	0.75%	1.86%	1.96%	4.53%	1.95%	1.17%	0.00%	0.00%
EBITDA Q/Q Growth	-3.44%	-42.88%	-2.06%	-8.43%	2.55%	6.77%	1.62%	12.37%	-5.62%	0.00%	0.00%
EBIT Q/Q Growth	-1.30%	-66.17%	-3.31%	-12.84%	4.96%	5.41%	5.18%	11.99%	-3.41%	0.00%	0.00%
NOPAT Q/Q Growth	37.31%	-67.23%	-2.82%	-5.53%	0.16%	1.27%	-3.67%	33.38%	10.28%	0.00%	0.00%
Net Income Q/Q Growth	23.67%	-104.25%	-6.08%	-12.39%	0.95%	1.21%	-3.14%	33.33%	8.29%	0.00%	0.00%
EPS Q/Q Growth	23.35%	-104.36%	-5.66%	-10.61%	1.16%	1.64%	0.51%	6.83%	295.24%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	16.59%	-20.32%	7.62%	-20.79%	23.82%	-0.04%	21.68%	-6.99%	15.02%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	26.96%	169.90%	-188.66%	-24.55%	45.91%	-8.40%	10.53%	-14.11%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-3.11%	-4.95%	22.11%	1.15%	-2.35%	2.40%	-0.05%	4.31%	-4.95%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	32.33%	27.89%	34.17%	36.85%	38.28%	37.28%	36.77%	33.83%	30.21%	28.74%	30.76%
EBITDA Margin	-23.98%	11.80%	25.94%	23.03%	30.47%	27.83%	26.61%	24.38%	15.17%	19.95%	24.22%
Operating Margin	-19.60%	4.88%	19.42%	20.87%	22.47%	20.92%	22.28%	19.65%	11.20%	16.24%	20.86%
EBIT Margin	-31.68%	4.54%	19.42%	15.13%	22.80%	21.25%	22.19%	19.60%	11.55%	16.34%	21.10%
Profit (Net Income) Margin	-30.60%	-0.32%	12.68%	8.49%	14.92%	14.21%	16.04%	14.93%	4.89%	8.80%	12.81%
Tax Burden Percent	80.34%	53.47%	78.49%	72.54%	77.16%	80.61%	81.97%	83.07%	51.03%	61.76%	65.61%
Interest Burden Percent	120.22%	-13.13%	83.24%	77.34%	84.78%	82.93%	88.16%	91.71%	82.94%	87.16%	92.49%
Effective Tax Rate	0.00%	0.00%	21.51%	27.46%	22.84%	19.39%	18.03%	16.93%	48.97%	38.24%	34.39%
Return on Invested Capital (ROIC)	-10.93%	2.82%	13.51%	12.59%	12.39%	15.92%	24.99%	25.68%	8.89%	33.44%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-28.48%	-1.75%	9.95%	3.47%	9.75%	12.25%	20.14%	22.39%	5.98%	-7.66%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-93.18%	-3.63%	17.33%	5.36%	18.54%	26.33%	33.98%	44.72%	4.73%	-0.85%	0.00%
Return on Equity (ROE)	-104.11%	-0.81%	30.84%	17.95%	30.93%	42.25%	58.97%	70.40%	13.62%	32.59%	0.00%
Cash Return on Invested Capital (CROIC)	15.95%	7.33%	-9.18%	13.18%	15.17%	-36.04%	-19.69%	17.51%	5.79%	-166.56%	0.00%
Operating Return on Assets (OROA)	-19.18%	2.87%	12.44%	8.76%	12.39%	15.90%	22.42%	21.63%	13.02%	20.11%	0.00%
Return on Assets (ROA)	-18.52%	-0.20%	8.13%	4.92%	8.11%	10.63%	16.20%	16.48%	5.51%	10.83%	0.00%
Return on Common Equity (ROCE)	-104.11%	-0.81%	30.84%	17.95%	30.93%	42.25%	57.63%	66.71%	13.38%	32.35%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-220.44%	-0.86%	30.30%	17.53%	28.25%	34.61%	53.68%	55.02%	34.96%	16.41%	0.00%
Net Operating Profit after Tax (NOPAT)	-193	58	254	211	211	218	207	159	52	96	142
NOPAT Margin	-13.72%	3.42%	15.24%	15.14%	17.33%	16.86%	18.26%	16.32%	5.71%	10.03%	13.69%
Net Nonoperating Expense Percent (NNEP)	17.55%	4.57%	3.57%	9.12%	2.64%	3.67%	4.85%	3.29%	2.91%	41.10%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-12.09%	2.76%	11.71%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	67.67%	72.11%	65.83%	63.15%	61.72%	62.72%	63.23%	66.17%	69.79%	71.26%	69.24%
SG&A Expenses to Revenue	11.85%	10.86%	11.92%	12.89%	12.29%	12.62%	11.68%	10.94%	12.54%	11.47%	10.44%
R&D to Revenue	2.00%	1.88%	1.82%	1.89%	1.86%	1.52%	1.90%	2.04%	1.94%	1.82%	0.00%
Operating Expenses to Revenue	51.93%	23.01%	14.76%	15.98%	15.81%	16.36%	14.48%	14.18%	19.01%	12.50%	9.90%
Earnings before Interest and Taxes (EBIT)	-446	77	324	211	277	275	252	191	105	157	219
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-337	200	433	320	371	360	302	237	138	191	251
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.59	2.71	3.77	4.18	4.87	6.89	10.37	11.25	18.19	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	42.63	12.04	21.53	0.00	0.00
Price to Revenue (P/Rev)	1.05	1.01	1.58	2.02	2.57	2.83	3.10	3.05	2.54	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	12.44	23.85	17.23	19.89	20.77	23.46	65.64	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	8.04%	4.19%	5.80%	5.03%	4.81%	4.26%	1.52%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.84	1.54	1.92	2.28	2.48	2.81	4.13	5.20	4.68	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.00	1.82	2.42	2.74	3.42	3.75	3.69	3.44	3.06	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	15.43	9.31	11.89	11.23	13.48	13.88	14.12	20.15	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	40.08	12.44	18.10	15.01	17.65	16.64	17.56	26.47	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	53.31	15.85	18.09	19.74	22.24	20.22	21.09	53.49	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	21.88	15.03	12.86	12.99	11.81	17.59	16.62	19.20	21.71	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	10.00	20.53	0.00	17.29	16.12	0.00	0.00	30.93	82.14	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	7.18	2.32	2.11	1.88	2.01	2.36	2.22	1.63	3.63	0.17	0.00
Long-Term Debt to Equity	6.86	2.19	2.11	1.86	1.97	2.31	2.19	1.60	3.58	0.15	0.00
Financial Leverage	3.27	2.08	1.74	1.54	1.90	2.15	1.69	2.00	0.79	0.11	0.00
Leverage Ratio	5.62	4.03	3.79	3.65	3.82	3.98	3.64	4.27	2.47	1.51	0.00
Compound Leverage Factor	6.76	-0.53	3.16	2.82	3.24	3.30	3.21	3.92	2.05	1.31	0.00
Debt to Total Capital	87.77%	69.91%	67.85%	65.33%	66.83%	70.21%	68.96%	62.00%	78.41%	14.73%	0.00%
Short-Term Debt to Total Capital	3.84%	4.02%	0.04%	1.01%	1.34%	1.26%	1.03%	1.29%	1.20%	1.55%	0.00%
Long-Term Debt to Total Capital	83.93%	65.89%	67.80%	64.32%	65.48%	68.95%	67.93%	60.71%	77.21%	13.18%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.91%	1.22%	0.63%	0.00%
Common Equity to Total Capital	12.23%	30.09%	32.15%	34.67%	33.17%	29.79%	31.04%	36.09%	20.37%	84.64%	0.00%
Debt to EBITDA	-4.15	7.35	3.41	3.96	3.49	3.48	2.49	1.91	3.55	0.47	0.00
Net Debt to EBITDA	-3.95	6.87	3.23	3.10	2.80	3.32	2.24	1.54	3.33	0.30	0.00
Long-Term Debt to EBITDA	-3.97	6.92	3.40	3.90	3.42	3.41	2.46	1.87	3.49	0.42	0.00
Debt to NOPAT	-7.26	25.38	5.80	6.03	6.14	5.74	3.63	2.86	9.42	0.93	0.00
Net Debt to NOPAT	-6.91	23.72	5.49	4.72	4.91	5.48	3.26	2.30	8.83	0.60	0.00
Long-Term Debt to NOPAT	-6.94	23.92	5.79	5.93	6.01	5.63	3.58	2.80	9.27	0.83	0.00
Altman Z-Score	0.99	1.93	2.46	2.46	2.64	2.85	4.20	4.95	3.75	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.27%	5.24%	1.75%	0.73%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.87	1.81	2.25	2.70	2.81	2.15	2.31	2.41	2.16	2.97	0.00
Quick Ratio	0.79	0.77	0.99	1.63	1.82	0.96	1.07	1.23	0.88	1.27	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	282	150	-173	220	258	-494	-163	108	34	-479	0.00
Operating Cash Flow to CapEx	165.72%	186.79%	219.93%	282.56%	429.23%	240.16%	268.37%	331.37%	225.57%	71.56%	136.05%
Free Cash Flow to Firm to Interest Expense	2.88	1.61	-2.80	4.26	5.48	-9.04	-4.91	5.98	1.75	-23.82	0.00
Operating Cash Flow to Interest Expense	1.31	2.20	5.07	5.67	7.48	5.05	7.59	9.63	6.63	3.59	8.45
Operating Cash Flow Less CapEx to Interest Expense	0.52	1.02	2.77	3.67	5.74	2.95	4.76	6.72	3.69	-1.43	2.24
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.63	0.64	0.58	0.54	0.75	1.01	1.10	1.13	1.23	0.00
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	9.62	10.36	10.25	9.82	10.07	0.00
Inventory Turnover	3.55	3.79	3.81	4.09	3.74	4.02	4.08	4.14	4.22	4.59	0.00
Fixed Asset Turnover	1.98	2.17	0.00	0.00	0.00	0.00	2.36	2.26	2.11	2.19	0.00
Accounts Payable Turnover	7.53	7.32	7.31	7.64	7.38	8.45	8.15	7.93	8.80	10.54	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	37.96	35.24	35.62	37.17	36.26	0.00
Days Inventory Outstanding (DIO)	102.71	96.29	95.75	89.35	97.62	90.90	89.47	88.27	86.40	79.58	0.00
Days Payable Outstanding (DPO)	48.50	49.84	49.95	47.77	49.43	43.21	44.81	46.04	41.46	34.63	0.00
Cash Conversion Cycle (CCC)	54.21	46.46	45.80	41.58	48.19	85.65	79.90	77.86	82.11	81.21	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,528	2,003	2,095	1,668	1,678	1,725	1,014	643	593	575	0.00
Invested Capital Turnover	0.80	0.83	0.89	0.83	0.71	0.94	1.37	1.57	1.56	3.33	0.00
Increase / (Decrease) in Invested Capital	-475	-92	427	-9.80	-47	712	370	51	18	575	0.00
Enterprise Value (EV)	2,814	3,082	4,029	3,811	4,162	4,849	4,187	3,347	2,776	0.00	0.00
Market Capitalization	1,481	1,711	2,632	2,817	3,126	3,655	3,512	2,968	2,310	0.00	0.00
Book Value per Share	$5.37	$17.43	$18.69	$17.15	$15.55	$12.69	$8.07	$6.27	$3.02	$12.20	$0.00
Tangible Book Value per Share	($7.12)	($6.41)	($6.02)	($2.69)	($4.28)	($7.22)	$1.96	$5.86	$2.55	$11.68	$0.00
Total Capital	1,596	2,099	2,172	1,943	1,936	1,782	1,091	731	623	607	0.00
Total Debt	1,401	1,467	1,473	1,270	1,293	1,251	752	453	489	89	0.00
Total Long-Term Debt	1,340	1,383	1,473	1,250	1,267	1,228	741	444	481	80	0.00
Net Debt	1,333	1,371	1,397	994	1,036	1,194	675	366	458	57	0.00
Capital Expenditures (CapEx)	78	110	143	104	82	115	94	53	57	101	102
Debt-free, Cash-free Net Working Capital (DFCFNWC)	222	284	304	200	174	214	173	137	135	174	0.00
Debt-free Net Working Capital (DFNWC)	290	380	381	476	431	270	251	225	166	206	0.00
Net Working Capital (NWC)	229	296	380	456	405	248	239	216	158	197	0.00
Net Nonoperating Expense (NNE)	237	63	43	93	29	34	25	14	7.50	12	9.12
Net Nonoperating Obligations (NNO)	1,333	1,371	1,397	994	1,036	1,194	675	366	458	57	0.00
Total Depreciation and Amortization (D&A)	108	123	109	110	93	85	50	47	33	35	32
Debt-free, Cash-free Net Working Capital to Revenue	15.81%	16.80%	18.22%	14.39%	14.28%	16.53%	15.27%	14.09%	14.90%	18.15%	0.00%
Debt-free Net Working Capital to Revenue	20.65%	22.46%	22.82%	34.18%	35.47%	20.90%	22.11%	23.13%	18.25%	21.49%	0.00%
Net Working Capital to Revenue	16.29%	17.48%	22.77%	32.77%	33.33%	19.16%	21.12%	22.16%	17.43%	20.51%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($11.85)	($0.15)	$5.54	$2.97	$4.39	$4.39	$4.02	$3.00	$0.83	$1.89	$3.06
Adjusted Weighted Average Basic Shares Outstanding	36.35M	36.24M	37.15M	39.00M	40.47M	41.83M	41.62M	42.08M	42.13M	42.10M	0.00
Adjusted Diluted Earnings per Share	($11.85)	($0.15)	$5.50	$2.95	$4.37	$4.35	$3.97	$2.97	$0.83	$1.89	$3.06
Adjusted Weighted Average Diluted Shares Outstanding	36.35M	36.24M	37.15M	39.00M	40.47M	41.83M	41.62M	42.08M	42.13M	42.10M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.35M	36.24M	37.15M	39.00M	40.47M	41.83M	41.62M	42.08M	42.13M	42.10M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	182	179	258	223	226	240	215	168	73	91	138
Normalized NOPAT Margin	12.94%	10.61%	15.47%	16.02%	18.62%	18.54%	19.01%	17.25%	8.03%	9.54%	13.33%
Pre Tax Income Margin	-38.08%	-0.60%	16.16%	11.70%	19.33%	17.63%	19.57%	17.98%	9.58%	14.24%	19.52%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-4.56	0.82	5.24	4.07	5.89	5.03	7.58	10.53	5.44	7.79	13.32
NOPAT to Interest Expense	-1.97	0.62	4.11	4.07	4.48	3.99	6.24	8.77	2.69	4.78	8.64
EBIT Less CapEx to Interest Expense	-5.35	-0.35	2.94	2.06	4.14	2.93	4.75	7.62	2.50	2.77	7.12
NOPAT Less CapEx to Interest Expense	-2.77	-0.56	1.81	2.07	2.73	1.89	3.41	5.86	-0.25	-0.24	2.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	52.42%	8.47%	1,022.30%	4.03%	2.34%
Augmented Payout Ratio	0.00%	-1,705.56%	68.62%	92.63%	48.51%	3.48%	78.49%	13.02%	1,022.30%	4.03%	2.34%

This table displays calculated financial ratios and metrics derived from Ingevity's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-16.50%	-19.61%	-15.49%	-18.93%	-13.37%	-3.10%	-7.47%	14.74%	2.56%	14.17%	27.92%
EBITDA Growth	455.50%	203.33%	-202.45%	-384.95%	-117.42%	-214.87%	-35.49%	-15.08%	-0.52%	-10.66%	340.40%
EBIT Growth	193.15%	150.97%	-306.70%	-549.35%	-159.26%	-388.33%	-48.56%	-24.35%	-5.21%	-21.13%	4,026.92%
NOPAT Growth	415.89%	237.34%	-103.63%	-522.64%	-123.51%	-354.88%	-48.44%	-26.69%	-23.91%	-19.77%	40.93%
Net Income Growth	136.61%	114.21%	-525.40%	-899.15%	-210.45%	-848.72%	-66.58%	-40.64%	-16.61%	-46.76%	1,895.24%
EPS Growth	136.36%	114.24%	-527.54%	-905.15%	-214.07%	-834.88%	-65.15%	-37.01%	-12.90%	-43.42%	1,900.00%
Operating Cash Flow Growth	309.92%	39.61%	-55.80%	-38.64%	-328.30%	-53.10%	5.09%	-46.52%	-78.19%	29.10%	0.00%
Free Cash Flow Firm Growth	174.52%	3,471.90%	252.23%	164.90%	144.76%	104.08%	-1,894.77%	-505.99%	-918.55%	-944.81%	-85.16%
Invested Capital Growth	-21.13%	-23.69%	-25.14%	-22.61%	-8.28%	-4.41%	22.80%	27.79%	24.44%	25.60%	4.04%
Revenue Q/Q Growth	-4.95%	-20.72%	-3.51%	14.85%	-8.50%	-16.66%	-7.43%	22.72%	2.35%	-20.41%	14.79%
EBITDA Q/Q Growth	-11.79%	191.70%	69.06%	-1,320.50%	76.08%	-190.91%	-13.94%	-13.15%	71.60%	-48.95%	13.29%
EBIT Q/Q Growth	-16.61%	148.55%	63.36%	-527.82%	54.37%	-296.92%	-20.35%	-17.20%	128.07%	-64.86%	17.14%
NOPAT Q/Q Growth	-63.18%	6,590.97%	99.26%	-1,689.66%	83.99%	-271.55%	-14.00%	-0.45%	81.73%	-65.30%	22.28%
Net Income Q/Q Growth	23.49%	115.49%	62.21%	-406.61%	52.05%	-563.49%	-29.01%	-29.98%	225.00%	-79.31%	26.09%
EPS Q/Q Growth	24.44%	115.25%	62.23%	-407.14%	51.27%	-557.97%	-28.87%	-28.15%	213.95%	-78.28%	28.57%
Operating Cash Flow Q/Q Growth	-60.62%	38.71%	56.57%	345.45%	-127.13%	-56.08%	117.36%	813.21%	-94.62%	-1.60%	10.61%
Free Cash Flow Firm Q/Q Growth	-21.33%	9.66%	93.32%	64.61%	923.57%	104.67%	17.58%	-13.52%	6.98%	-2,155.06%	-81.36%
Invested Capital Q/Q Growth	1.83%	-3.11%	-6.19%	-14.78%	-1.48%	-4.95%	-3.02%	0.99%	2.68%	22.11%	0.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	39.93%	34.10%	34.47%	31.54%	29.31%	16.01%	28.92%	31.76%	33.21%	27.48%	36.58%
EBITDA Margin	25.04%	26.97%	-23.32%	-72.73%	-5.88%	-20.98%	19.24%	20.69%	29.24%	17.70%	27.59%
Operating Margin	17.71%	18.54%	-0.61%	-79.72%	-5.12%	-29.24%	12.67%	14.38%	16.68%	9.83%	22.68%
EBIT Margin	16.27%	18.54%	-30.27%	-79.72%	-14.58%	-29.24%	12.38%	14.38%	21.32%	9.83%	22.26%
Profit (Net Income) Margin	7.22%	5.56%	-28.44%	-72.63%	-16.47%	-31.42%	5.65%	7.37%	12.91%	4.07%	15.64%
Tax Burden Percent	76.49%	188.64%	77.74%	84.79%	77.89%	75.84%	78.50%	74.42%	79.10%	79.19%	78.71%
Interest Burden Percent	58.01%	15.88%	120.86%	107.45%	144.96%	141.67%	58.15%	68.83%	76.58%	52.25%	89.28%
Effective Tax Rate	23.51%	-88.64%	0.00%	0.00%	0.00%	0.00%	21.50%	25.58%	20.90%	20.81%	21.29%
Return on Invested Capital (ROIC)	10.37%	27.86%	-0.34%	-44.84%	-2.85%	-16.91%	8.87%	9.62%	11.41%	6.90%	17.19%
ROIC Less NNEP Spread (ROIC-NNEP)	9.05%	21.36%	-8.02%	-49.45%	-5.94%	-19.85%	7.32%	8.34%	11.33%	5.71%	16.18%
Return on Net Nonoperating Assets (RNNOA)	30.73%	69.88%	-23.64%	-141.33%	-13.00%	-41.32%	13.36%	15.25%	19.80%	9.95%	26.40%
Return on Equity (ROE)	41.10%	97.75%	-23.98%	-186.17%	-15.85%	-58.22%	22.23%	24.87%	31.21%	16.85%	43.59%
Cash Return on Invested Capital (CROIC)	15.38%	15.95%	12.04%	11.65%	8.63%	7.33%	-11.24%	-13.12%	-9.58%	-9.18%	11.58%
Operating Return on Assets (OROA)	9.50%	11.23%	-17.99%	-48.37%	-8.96%	-18.46%	8.27%	9.64%	13.69%	6.30%	15.15%
Return on Assets (ROA)	4.22%	3.36%	-16.90%	-44.06%	-10.11%	-19.84%	3.77%	4.94%	8.29%	2.61%	10.65%
Return on Common Equity (ROCE)	41.10%	97.75%	-23.98%	-186.17%	-15.85%	-58.22%	22.23%	24.87%	31.21%	16.85%	43.59%
Return on Equity Simple (ROE_SIMPLE)	-150.81%	0.00%	-262.80%	-151.44%	-19.73%	0.00%	17.67%	24.81%	27.77%	0.00%	35.54%
Net Operating Profit after Tax (NOPAT)	38	105	-1.61	-218	-12	-76	44	52	52	30	86
NOPAT Margin	13.55%	34.97%	-0.43%	-55.81%	-3.58%	-20.47%	9.95%	10.70%	13.20%	7.78%	17.85%
Net Nonoperating Expense Percent (NNEP)	1.32%	6.50%	7.68%	4.60%	3.10%	2.94%	1.55%	1.28%	0.09%	1.19%	1.02%
Return On Investment Capital (ROIC_SIMPLE)	2.36%	6.55%	-	-	-	-3.63%	-	-	-	1.37%	-
Cost of Revenue to Revenue	60.07%	65.90%	65.53%	68.46%	70.69%	83.99%	71.08%	68.24%	66.79%	72.52%	63.42%
SG&A Expenses to Revenue	15.18%	13.19%	10.27%	10.60%	13.88%	11.68%	8.97%	10.73%	12.38%	14.57%	11.24%
R&D to Revenue	2.71%	2.44%	1.78%	1.87%	2.00%	1.94%	1.75%	1.66%	2.24%	1.88%	1.58%
Operating Expenses to Revenue	22.22%	15.56%	35.08%	111.26%	34.43%	45.25%	16.26%	17.37%	16.53%	17.65%	13.90%
Earnings before Interest and Taxes (EBIT)	46	55	-114	-311	-50	-109	55	69	84	38	107
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	71	81	-88	-284	-20	-78	86	100	115	68	133
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.13	7.59	6.61	5.58	3.04	2.71	2.40	2.96	3.66	3.77	3.64
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.07	1.05	0.96	1.03	1.05	1.01	1.01	1.21	1.58	1.58	1.42
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	13.58	11.92	13.19	12.44	10.24
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.36%	8.39%	7.58%	8.04%	9.77%
Enterprise Value to Invested Capital (EV/IC)	1.77	1.84	1.76	1.78	1.59	1.54	1.48	1.64	1.90	1.92	1.98
Enterprise Value to Revenue (EV/Rev)	2.04	2.00	1.88	1.93	1.91	1.82	1.83	2.05	2.43	2.42	2.09
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	48.28	15.43	8.90	8.98	9.45	9.31	7.67
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	40.08	13.69	12.75	12.79	12.44	10.12
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	53.31	17.64	16.36	17.25	15.85	12.95
Enterprise Value to Operating Cash Flow (EV/OCF)	16.62	21.88	25.21	17.66	16.69	15.03	12.09	14.16	13.87	12.86	11.64
Enterprise Value to Free Cash Flow (EV/FCFF)	10.17	10.00	12.54	13.30	17.61	20.53	0.00	0.00	0.00	0.00	17.39
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.94	7.18	6.99	5.28	2.63	2.32	2.05	2.14	2.07	2.11	1.82
Long-Term Debt to Equity	5.68	6.86	6.52	4.92	2.48	2.19	2.04	2.14	2.07	2.11	1.82
Financial Leverage	3.40	3.27	2.95	2.86	2.19	2.08	1.83	1.83	1.75	1.74	1.63
Leverage Ratio	5.76	5.62	5.33	5.11	4.13	4.03	3.77	3.80	3.70	3.79	3.72
Compound Leverage Factor	3.34	0.89	6.45	5.49	5.98	5.71	2.19	2.61	2.84	1.98	3.33
Debt to Total Capital	85.59%	87.77%	87.48%	84.08%	72.44%	69.91%	67.20%	68.13%	67.44%	67.85%	64.55%
Short-Term Debt to Total Capital	3.71%	3.84%	5.88%	5.76%	4.11%	4.02%	0.14%	0.04%	0.04%	0.04%	0.05%
Long-Term Debt to Total Capital	81.88%	83.93%	81.60%	78.32%	68.33%	65.89%	67.07%	68.09%	67.40%	67.80%	64.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	14.41%	12.23%	12.52%	15.92%	27.56%	30.09%	32.80%	31.87%	32.56%	32.15%	35.45%
Debt to EBITDA	-5.66	-4.15	-4.60	-5.72	23.01	7.35	4.21	3.84	3.48	3.41	2.61
Net Debt to EBITDA	-5.37	-3.95	-4.18	-5.31	21.65	6.87	3.97	3.67	3.30	3.23	2.45
Long-Term Debt to EBITDA	-5.41	-3.97	-4.29	-5.33	21.71	6.92	4.20	3.84	3.48	3.40	2.61
Debt to NOPAT	-9.57	-7.26	-4.87	-5.64	-7,111.43	25.38	8.35	6.99	6.35	5.80	4.41
Net Debt to NOPAT	-9.08	-6.91	-4.43	-5.24	-6,690.00	23.72	7.87	6.68	6.02	5.49	4.14
Long-Term Debt to NOPAT	-9.15	-6.94	-4.54	-5.25	-6,708.10	23.92	8.33	6.99	6.35	5.79	4.41
Altman Z-Score	1.76	1.80	1.43	1.29	1.76	1.69	1.94	2.03	2.21	2.11	2.44
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.00	1.87	1.77	1.92	1.90	1.81	2.41	2.46	2.57	2.25	2.22
Quick Ratio	0.89	0.79	0.90	0.90	0.80	0.77	0.99	1.05	1.14	0.99	1.10
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	455	579	528	273	166	16	-347	-421	-371	-397	19
Operating Cash Flow to CapEx	396.88%	259.04%	258.33%	164.09%	-72.89%	158.22%	314.03%	223.04%	20.87%	200.20%	277.29%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.61	0.59	0.61	0.61	0.63	0.67	0.67	0.64	0.64	0.68
Accounts Receivable Turnover	7.61	0.00	7.28	6.55	7.60	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	3.09	3.55	3.29	3.30	3.49	3.79	3.55	3.54	3.59	3.81	4.12
Fixed Asset Turnover	1.95	1.98	2.01	2.03	2.14	2.17	2.24	0.00	2.20	0.00	2.28
Accounts Payable Turnover	6.75	7.53	7.26	6.57	7.33	7.32	6.56	6.32	7.37	7.31	7.20
Days Sales Outstanding (DSO)	47.98	0.00	50.15	55.76	48.05	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	118.14	102.71	110.78	110.61	104.61	96.29	102.85	103.16	101.71	95.75	88.58
Days Payable Outstanding (DPO)	54.09	48.50	50.25	55.54	49.80	49.84	55.68	57.77	49.54	49.95	50.70
Cash Conversion Cycle (CCC)	112.03	54.21	110.68	110.83	102.86	46.46	47.17	45.39	52.16	45.80	37.87
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,556	1,528	1,577	1,681	1,973	2,003	2,107	2,173	2,151	2,095	1,716
Invested Capital Turnover	0.77	0.80	0.80	0.80	0.80	0.83	0.89	0.90	0.87	0.89	0.96
Increase / (Decrease) in Invested Capital	-417	-475	-530	-491	-178	-92	391	472	423	427	67
Enterprise Value (EV)	2,761	2,814	2,780	2,985	3,133	3,082	3,113	3,571	4,083	4,029	3,389
Market Capitalization	1,439	1,481	1,417	1,588	1,728	1,711	1,725	2,113	2,657	2,632	2,307
Book Value per Share	$6.45	$5.37	$5.90	$7.84	$15.64	$17.43	$19.84	$19.66	$19.53	$18.69	$16.66
Tangible Book Value per Share	($6.13)	($7.12)	($7.46)	($5.17)	($7.17)	($6.41)	($4.89)	($5.70)	($5.25)	($6.02)	($0.68)
Total Capital	1,628	1,596	1,713	1,789	2,062	2,099	2,191	2,241	2,229	2,172	1,788
Total Debt	1,393	1,401	1,498	1,504	1,493	1,467	1,473	1,526	1,503	1,473	1,154
Total Long-Term Debt	1,333	1,340	1,398	1,401	1,409	1,383	1,470	1,526	1,503	1,473	1,153
Net Debt	1,322	1,333	1,363	1,397	1,405	1,371	1,388	1,458	1,426	1,397	1,082
Capital Expenditures (CapEx)	6.40	25	18	18	17	29	34	22	25	49	36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	254	222	241	324	314	284	348	386	361	304	283
Debt-free Net Working Capital (DFNWC)	326	290	377	431	402	380	432	454	438	381	356
Net Working Capital (NWC)	265	229	276	328	318	296	429	453	438	380	355
Net Nonoperating Expense (NNE)	18	88	106	66	44	41	19	16	1.11	14	11
Net Nonoperating Obligations (NNO)	1,322	1,333	1,363	1,397	1,405	1,371	1,388	1,458	1,426	1,397	1,082
Total Depreciation and Amortization (D&A)	25	25	26	27	30	31	31	30	31	30	26
Debt-free, Cash-free Net Working Capital to Revenue	18.83%	15.81%	16.31%	20.90%	19.13%	16.80%	20.42%	22.20%	21.48%	18.22%	17.49%
Debt-free Net Working Capital to Revenue	24.13%	20.65%	25.46%	27.84%	24.53%	22.46%	25.38%	26.10%	26.12%	22.82%	21.95%
Net Working Capital to Revenue	19.65%	16.29%	18.66%	21.18%	19.36%	17.48%	25.20%	26.05%	26.07%	22.77%	21.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.56	$0.45	($2.95)	($7.81)	($1.54)	($3.19)	$0.70	$0.98	$1.36	$0.44	$1.99
Adjusted Weighted Average Basic Shares Outstanding	36.46M	36.35M	36.35M	36.35M	36.33M	36.24M	36.23M	36.22M	36.33M	37.15M	37.37M
Adjusted Diluted Earnings per Share	$0.56	$0.45	($2.95)	($7.81)	($1.54)	($3.16)	$0.69	$0.97	$1.35	$0.43	$1.98
Adjusted Weighted Average Diluted Shares Outstanding	36.46M	36.35M	36.35M	36.35M	36.33M	36.24M	36.23M	36.22M	36.33M	37.15M	37.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.46M	36.35M	36.35M	36.35M	36.33M	36.24M	36.23M	36.22M	36.33M	37.15M	37.37M
Normalized Net Operating Profit after Tax (NOPAT)	38	99	59	35	-12	12	64	67	53	32	88
Normalized NOPAT Margin	13.55%	33.24%	15.69%	9.07%	-3.52%	3.30%	14.29%	13.95%	13.58%	8.42%	18.16%
Pre Tax Income Margin	9.44%	2.95%	-36.59%	-85.66%	-21.14%	-41.43%	7.20%	9.90%	16.33%	5.14%	19.88%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	-52.36%	-1,705.56%	77.24%	83.18%	68.59%	68.62%	65.82%

Frequently Asked Questions About Ingevity's Financials

When does Ingevity's fiscal year end?

According to the most recent income statement we have on file, Ingevity's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ingevity's net income changed over the last 10 years?

Ingevity's net income appears to be on a downward trend, with a most recent value of -$430.30 million in 2024, falling from $132.60 million in 2014. The previous period was -$5.40 million in 2023. See Ingevity's forecast for analyst expectations on what’s next for the company.

What is Ingevity's operating income?

Ingevity's total operating income in 2024 was -$275.70 million, based on the following breakdown:

Total Gross Profit: $454.70 million
Total Operating Expenses: $730.40 million

How has Ingevity revenue changed over the last 10 years?

Over the last 10 years, Ingevity's total revenue changed from $1.04 billion in 2014 to $1.41 billion in 2024, a change of 35.8%.

How much debt does Ingevity have?

Ingevity's total liabilities were at $1.83 billion at the end of 2024, a 8.3% decrease from 2023, and a 599.3% increase since 2015.

How much cash does Ingevity have?

In the past 9 years, Ingevity's cash and equivalents has ranged from $30.50 million in 2016 to $275.40 million in 2021, and is currently $68 million as of their latest financial filing in 2024.

How has Ingevity's book value per share changed over the last 10 years?

Over the last 10 years, Ingevity's book value per share changed from 0.00 in 2014 to 5.37 in 2024, a change of 537.0%.

Related Companies

This page (NYSE:NGVT) was last updated on 5/31/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ingevity (NGVT) Financials

Frequently Asked Questions About Ingevity's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ingevity (NGVT) Financials

Annual Income Statements for Ingevity

Quarterly Income Statements for Ingevity

Annual Cash Flow Statements for Ingevity

Quarterly Cash Flow Statements for Ingevity

Annual Balance Sheets for Ingevity

Quarterly Balance Sheets for Ingevity

Annual Metrics And Ratios for Ingevity

Quarterly Metrics And Ratios for Ingevity

Frequently Asked Questions About Ingevity's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools